Stock PAREXEL INTERNATIONAL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

PAREXEL International Corporation Share Price

Equities

US6994621075

Biotechnology & Medical Research

Chart PAREXEL International Corporation

Dynamic Chart

Latest news about PAREXEL International Corporation

PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion RE
PAREXEL International : Pamplona Capital to take Parexel private for $4.5 billion RE
PAREXEL International : Contract research firm Parexel International explores sale - sources RE
More news

Press releases PAREXEL International Corporation

Parexel : Launches Enhanced Integrated Functional Service Provider Model to Drive Delivery of Innovative Clinical Research Partnerships BU
PAREXEL International : Launches Perceptive® Cloud for the Life Sciences Industry BU
PAREXEL International : Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry BU
PAREXEL International : Pamplona Capital Management Completes Acquisition of PAREXEL International BU
PAREXEL International : Receives Shareholder Approval for Proposed Acquisition by Pamplona Capital Management BU
More press releases

News in other languages on PAREXEL International Corporation

PAREXEL : ERWEITERT SEINE CLINICAL TRIAL SUPPLY UND LOGISTIK-SERVICES MIT DER ERÖFFUNG SEINES NEUEN EUROPÄISCHEN DISTRIBUTIONS- UND DIENSTLEISTUNGSZENTRUMS
More news

Managers and Directors - PAREXEL International Corporation

Managers TitleAgeSince
Duncan MacDonald CEO
 Chief Executive Officer 56 -
Gregory Rush DFI
 Director of Finance/CFO 56 -
Amy McKee CTO
 Chief Tech/Sci/R&D Officer 52 31/12/18
Members of the board TitleAgeSince
Sherilyn McCoy CHM
 Chairman 65 -
Duncan MacDonald CEO
 Chief Executive Officer 56 -
May Kin Ho BRD
 Director/Board Member 71 25/08/15
More insiders

Company Profile

More about the company

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. Stock